Ligand Pharmaceuticals Inc 10-Q for FY2026 Q2
Ligand Pharmaceuticals Inc (LGND)
10-Q
2026-08-07
For: 2026-06-30
View Original
Added on
August 07, 2026
About this 10-Q
Ligand Pharmaceuticals Inc filed this 10-Q on August 7, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $63.69M
- up 33.7% from $47.63M a year earlier
- Net income
- $48.51M
- up 900.8% from net income of $4.85M a year earlier
- Diluted EPS
- $2.22
- up 825.0% from $0.24 a year earlier